Cibc Asset Management Has Increased By $4.53 Million Its Valeant Pharmaceuticals Intl (VRX) Holding; Profile of 8 Analysts Covering Paragon Banking Group PLC (LON:PAG)

June 16, 2018 - By Lawrence Diaz

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Logo

Cibc Asset Management Inc increased Valeant Pharmaceuticals Intl (VRX) stake by 242.28% reported in 2018Q1 SEC filing. Cibc Asset Management Inc acquired 301,776 shares as Valeant Pharmaceuticals Intl (VRX)’s stock rose 17.86%. The Cibc Asset Management Inc holds 426,335 shares with $6.78M value, up from 124,559 last quarter. Valeant Pharmaceuticals Intl now has $9.38 billion valuation. The stock increased 0.22% or $0.06 during the last trading session, reaching $26.86. About 6.07M shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has risen 73.89% since June 16, 2017 and is uptrending. It has outperformed by 61.32% the S&P500. Some Historical VRX News: ; 12/04/2018 – newsbox.ch/ Cosmo Pharmaceuticals announces unfavourable award of Arbitral Tribunal in respect of request to terminate Uceris License Agreement with Valeant; 07/05/2018 – Valeant Discloses It Reached Settlement Related to Former Relationship With Philidor Rx Services; 17/05/2018 – VALEANT ANNOUNCES PRICING OF PRIVATE OFFERING OF NOTES; 06/03/2018 – VALEANT VRX.N : MORGAN STANLEY SAYS BAUSCH & LOMB/INTERNATIONAL SEGMENT AND NEW PRODUCT DRIVERS SHOULD HELP CO RETURN TO GROWTH IN 2019; 03/05/2018 – Ex-Valeant official accused of kickback scheme faces trial; 14/05/2018 – S&PGR Rates Valeant Pharmaceuticals Int’l Debt ‘BB-‘; 22/05/2018 – FORMER VALEANT PHARMACEUTICALS INTERNATIONAL, PHILIDOR EXECUTIVES FOUND GUILTY OF DEFRAUDING VALEANT -NEW YORK COURT PROCEEDING; 08/05/2018 – VALEANT CEO: ‘STRONG’ IP FOR XIFAXAN, PATENTS RUN THROUGH 2029; 17/05/2018 – LISTEN: Inside the Theranos collapse, Valeant’s latest legal lumps, and a bunch of biotech hot takes; 19/04/2018 – Novartis CEO feels heat on U.S. generics, Cosentyx drop

Among 13 analysts covering Paragon Group of Companies The PLC (LON:PAG), 8 have Buy rating, 4 Sell and 1 Hold. Therefore 62% are positive. Paragon Group of Companies The PLC had 133 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Numis Securities on Thursday, June 1 with “Hold”. JP Morgan downgraded it to “Underweight” rating and GBX 230 target in Wednesday, June 29 report. Shore Capital maintained the stock with “Buy” rating in Thursday, May 24 report. Peel Hunt maintained the stock with “Buy” rating in Thursday, September 21 report. As per Tuesday, January 23, the company rating was maintained by Peel Hunt. The stock of Paragon Banking Group PLC (LON:PAG) has “Hold” rating given on Tuesday, November 24 by Panmure Gordon. The rating was maintained by Canaccord Genuity on Thursday, November 23 with “Hold”. The company was maintained on Monday, August 1 by Liberum Capital. The firm has “Buy” rating by Peel Hunt given on Monday, December 14. As per Thursday, November 23, the company rating was maintained by Liberum Capital. See Paragon Banking Group PLC (LON:PAG) latest ratings:

29/05/2018 Broker: Numis Securities Rating: Reduce Old Target: GBX 452.00 Upgrade
24/05/2018 Broker: Peel Hunt Rating: Add Old Target: GBX 510.00 New Target: GBX 550.00 Maintain
24/05/2018 Broker: Shore Capital Rating: Buy Old Target: GBX 515.00 New Target: GBX 570.00 Maintain
08/05/2018 Broker: Peel Hunt Rating: Add Old Target: GBX 550.00 Maintain
26/04/2018 Broker: Peel Hunt Rating: Add Old Target: GBX 510.00 New Target: GBX 550.00 Maintain
20/04/2018 Broker: Shore Capital Rating: Buy New Target: GBX 515.00 Maintain
23/03/2018 Broker: Liberum Capital Rating: Buy Maintain
12/02/2018 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 500.00 New Target: GBX 550.00 Upgrade
24/01/2018 Broker: Barclays Capital Rating: Equal Weight New Target: GBX 490.00 Maintain
23/01/2018 Broker: Numis Securities Rating: Under Review Under Review

Among 28 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 9 have Buy rating, 5 Sell and 14 Hold. Therefore 32% are positive. Valeant Pharmaceuticals Intl had 171 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by H.C. Wainwright given on Monday, May 7. BMO Capital Markets maintained the shares of VRX in report on Tuesday, July 25 with “Hold” rating. Stifel Nicolaus maintained the shares of VRX in report on Thursday, May 11 with “Buy” rating. Deutsche Bank maintained the stock with “Hold” rating in Monday, November 14 report. Morgan Stanley downgraded the shares of VRX in report on Friday, October 2 to “Equal-Weight” rating. The stock has “Market Perform” rating by BMO Capital Markets on Wednesday, June 29. On Tuesday, November 7 the stock rating was maintained by Mizuho with “Sell”. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has “Neutral” rating given on Wednesday, March 16 by Nomura. RBC Capital Markets maintained the shares of VRX in report on Tuesday, February 14 with “Sector Perform” rating. The firm has “Hold” rating given on Monday, August 21 by H.C. Wainwright.

Cibc Asset Management Inc decreased At&T Inc (NYSE:T) stake by 55,329 shares to 702,816 valued at $25.01 million in 2018Q1. It also reduced Crown Holdings Inc (NYSE:CCK) stake by 8,390 shares and now owns 5,552 shares. Philip Morris Intl Inc (NYSE:PM) was reduced too.

More notable recent Valeant Pharmaceuticals International, Inc. (NYSE:VRX) news were published by: Finance.Yahoo.com which released: “Can Sprout Pharma’s Latest Revival Really Boost VRX Stock?” on June 15, 2018, also Seekingalpha.com with their article: “Valeant: Much Ado About Nothing” published on May 21, 2018, Finance.Yahoo.com published: “Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play” on June 15, 2018. More interesting news about Valeant Pharmaceuticals International, Inc. (NYSE:VRX) were released by: Seekingalpha.com and their article: “Key events next week – healthcare” published on June 15, 2018 as well as Schaeffersresearch.com‘s news article titled: “Options Bulls Blitz Booming Valeant Pharmaceuticals Stock” with publication date: June 05, 2018.

Since March 8, 2018, it had 4 buys, and 0 selling transactions for $1.20 million activity. DE SCHUTTER RICHARD U bought $153,400 worth of stock. PAPA JOSEPH C bought $481,500 worth of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Tuesday, March 13. Herendeen Paul bought 15,000 shares worth $241,470.

Investors sentiment increased to 1.06 in Q1 2018. Its up 0.09, from 0.97 in 2017Q4. It improved, as 29 investors sold VRX shares while 90 reduced holdings. 52 funds opened positions while 74 raised stakes. 167.32 million shares or 1.38% less from 169.66 million shares in 2017Q4 were reported. The Germany-based Deutsche Bank Ag has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Private Group Inc reported 1.25M shares stake. Stifel Fin holds 0.01% or 211,522 shares in its portfolio. Riverhead Cap Llc holds 1,000 shares. Point72 Asset Mgmt Limited Partnership reported 500,000 shares stake. Tekla Capital Mngmt Limited Liability Company owns 192,000 shares. Kazazian Asset Mngmt Ltd Liability invested 1.93% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Legal And General Group Incorporated Public Limited Co stated it has 0.02% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Tuttle Tactical Management holds 1.06% or 82,416 shares in its portfolio. Two Sigma Secs Limited Liability Corporation holds 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) or 27,084 shares. Amundi Pioneer Asset Mgmt holds 0% or 72,110 shares in its portfolio. Alliancebernstein LP invested 0% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Vanguard Group Inc Inc invested in 8.25 million shares. Susquehanna International Gru Llp holds 0.02% or 3.20 million shares in its portfolio.

Investors sentiment decreased to 0.9 in Q1 2018. Its down 0.18, from 1.08 in 2017Q4. It dived, as 29 investors sold Paragon Banking Group PLC shares while 72 reduced holdings. 36 funds opened positions while 55 raised stakes. 35.06 million shares or 1.98% more from 34.38 million shares in 2017Q4 were reported. Brandywine Management Limited Liability Co accumulated 246,220 shares. Canada Pension Plan Investment Board reported 8,500 shares stake. Koch invested in 10,831 shares. Steinberg Asset Management reported 6,297 shares stake. Barrow Hanley Mewhinney And Strauss Lc reported 0% stake. D E Shaw & Com holds 27,993 shares. Quantbot Limited Partnership reported 25,520 shares. State Of New Jersey Common Pension Fund D owns 0.03% invested in Paragon Banking Group PLC (LON:PAG) for 154,750 shares. Gotham Asset Ltd Llc reported 0.05% of its portfolio in Paragon Banking Group PLC (LON:PAG). Comerica Bank reported 59,691 shares. Point72 Asia (Hong Kong) has 1,162 shares for 0.03% of their portfolio. Citigroup Inc stated it has 0% in Paragon Banking Group PLC (LON:PAG). Ftb Incorporated has 0% invested in Paragon Banking Group PLC (LON:PAG) for 270 shares. Gilder Gagnon Howe & Lc reported 75,688 shares stake. Vanguard Gru holds 2.84 million shares.

Paragon Banking Group PLC, through its subsidiaries, engages in the mortgage and consumer finance businesses in the United Kingdom. The company has market cap of 1.25 billion GBP. It operates through three divisions: Paragon Mortgages, Idem Capital, and Paragon Bank. It has a 10.76 P/E ratio. It originates and services buy-to-let mortgages to landlords and residential property investors; and provides mortgage related ancillary services, including landlord insurance.

Since March 27, 2018, it had 1 buy, and 3 sales for $50.15 million activity. Spradlin Shane M. sold 2,150 shares worth $103,953. The insider MCWATERS KIMBERLY J sold 5,000 shares worth $242,886. Another trade for 4,000 shares valued at $194,056 was made by THOMPSON H BRIAN on Friday, May 18. $50.00M worth of Paragon Banking Group PLC (LON:PAG) was sold by MITSUI & CO LTD.

The stock decreased 0.70% or GBX 3.4 during the last trading session, reaching GBX 484. About 971,196 shares traded or 26.70% up from the average. Paragon Banking Group PLC (LON:PAG) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500. Some Historical PAG News: ; 11/04/2018 – JOYSON, PAG FUND KSS TO BUY AIR-BAG MAKER TAKATA IN ASSET DEAL; 25/04/2018 – PENSKE AUTOMOTIVE 1Q REV. $5.7B, EST. $5.32B; 14/03/2018 – Penske Media Corporation Elevates Paul Jowdy to Chief Business Officer and Publisher, WWD & Fairchild Live; 01/05/2018 – Folio: Once a Side Gig, Licensing Has Become a Crucial Revenue Source for PublishersExecs from Meredith Corp., Penske Media, an; 26/04/2018 – Penske Truck Leasing Returns as a Top Sponsor of National Private Truck Council Expo; 25/04/2018 – PENSKE AUTOMOTIVE GROUP INC QTRLY TOTAL AUTOMOTIVE RETAIL UNIT VOLUME INCREASED 6.4%; 25/04/2018 – Penske Auto 1Q Rev $5.8B; 25/04/2018 – Penske Automotive Closes Above 200-Day Average: Technicals; 27/03/2018 – PENSKE IN SHARE PURCHASE AGREEMENT W/ MITSUI JAPAN, MITSUI USA; 03/04/2018 – Penske Logistics Adds Video-Based Safety Program to its Dedicated Trucking Fleet

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>